newsfilter
← Latest News
GlobeNewswire·

Jade Biosciences to Participate in Upcoming Conferences

  • Jade Biosciences, Inc. (NASDAQ: JBIO) announced participation in five upcoming conferences scheduled for November 2025.
  • The company will hold a fireside chat at the Wedbush Rewind ASN Conference on November 10, 2025, at 12:40 p.m. ET.
  • Jade will present at the Stifel Healthcare Conference on November 12, 2025, at 4:00 p.m. ET.
  • A presentation is scheduled for the TD Cowen Immunology & Inflammation Virtual Summit on November 13, 2025, at 3:00 p.m. ET.
  • The company will present at the Jefferies Global Healthcare Conference in London on November 17, 2025, at 3:30 p.m. GMT.
  • Live webcasts & archived replays (available for 90 days) will be accessible on the company's website.
  • Lead candidate JADE101 targets the cytokine APRIL & is in a Phase 1 trial for immunoglobulin A nephropathy.
  • JADE201 is an afucosylated anti-BAFF-R monoclonal antibody currently in preclinical development.
  • JADE-003 is an undisclosed antibody discovery program also in preclinical development.
  • Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.